The dual actions of angiogenesis and anti-apoptosis induced by an isolated fraction from Geum japonicum repair muscle ischemia

被引:17
作者
Cheung, Winghong L.
Cheng, Lei
Liu, Hongwei
Gu, Xuemei
Li, Ming [1 ]
机构
[1] Chinese Univ Hong Kong, Epithelial Cell Biol Res Ctr, Hong Kong, Hong Kong, Peoples R China
[2] Capital Med Univ, Sch Chem Biol & Pharmaceut Sci, Beijing, Peoples R China
关键词
muscle ischemia; HCAECs; angiogenic factor; neovascularization; anti-apoptosis;
D O I
10.1016/j.abb.2006.10.021
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The fundamental improvement of muscle ischemia requires the re-establishment of sufficient vessel network. Despite many kinds of drugs have been used for ischemia, effective angiogenic drug is very limited. Here, we reported the identification and isolation of a potent angiogenic fraction (angio-T) from Geum japonicum and assessment of its therapeutic effects on muscle ischemia by reconstituting the insufficient blood supply network and enhancing cell survival potential. It was demonstrated that angio-T not only significantly enhanced the proliferation of cultured HCAECs in vitro, but also significantly enhanced the survival potential of the myofibers at risk and neovascularization in ischemic muscles leading to reconstitution of these vessel networks, significant reduction of ischemic areas, and significant myofiber regeneration in ischemic area one week post-ischemia. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:91 / 97
页数:7
相关论文
共 22 条
[1]   The role of the complement system in ischemia-reperfusion injury [J].
Arumugam, TV ;
Shiels, IA ;
Woodruff, TM ;
Granger, DN ;
Taylor, SM .
SHOCK, 2004, 21 (05) :401-409
[2]  
Carden DL, 2000, J PATHOL, V190, P255, DOI 10.1002/(SICI)1096-9896(200002)190:3<255::AID-PATH526>3.0.CO
[3]  
2-6
[4]  
CHAUDRY IH, 2004, VASC TRAUMA, P73
[5]   A new function of a previously isolated compound that stimulates activation and differentiation of myogenic precursor cells leading to efficient myofiber regeneration and muscle repair [J].
Cheng, L ;
Gu, XM ;
Sanderson, JE ;
Wang, XS ;
Lee, KM ;
Yao, XS ;
Liu, HW ;
Cheung, WHL ;
Li, M .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2006, 38 (07) :1123-1133
[6]  
Cosmi B., 2004, Current Drug Targets - Cardiovascular & Haematological Disorders, V4, P269, DOI 10.2174/1568006043336005
[7]  
Diehm Curt, 2004, Current Drug Targets - Cardiovascular & Haematological Disorders, V4, P241, DOI 10.2174/1568006043336069
[8]  
Eberhardt Robert T., 2004, Current Drug Targets - Cardiovascular & Haematological Disorders, V4, P209, DOI 10.2174/1568006043336230
[9]  
HIATT WR, 2004, CURR DRUG TARGETS CA, V4, P27
[10]   Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization [J].
Isner, JM ;
Asahara, T .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (09) :1231-1236